Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise Kostos

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cancer Cell|November 4, 2022
KIT as a therapeutic target in neuroendocrine prostate cancerArun A Azad, Louise Kostos, Neeraj Agarwal
World Journal of Urology|August 27, 2022
Future directions in systemic treatment of metastatic hormone-sensitive prostate cancerKenneth Chen, Louise Kostos, Arun A Azad
Drugs|July 26, 2024
Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate CancerLouise Kostos, Ben Tran, Arun A Azad
Platelets|June 2, 2015
Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case reportLouise Kostos, Kate Burbury, Gaurav Srivastava, et al.
Seminars in Nuclear Medicine|June 19, 2024
Combination Strategies and Targeted Radionuclide TherapiesKerry Jewell, Louise Kostos, Brittany Emmerson, et al.
European Urology Focus|May 30, 2026
Radionuclide Combination Strategies in Prostate Cancer: Insights from the AlphaBet TrialLouise Kostos, James P Buteau, Arun A Azad, et al.
Therapeutic Advances in Medical Oncology|June 16, 2023
Determinants of outcome following PSMA-based radioligand therapy and mechanisms of resistance in patients with metastatic castration-resistant prostate cancerLouise Kostos, James P Buteau, Michael S Hofman, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 24, 2022
Predictors and Real-World Use of Prostate-Specific Radioligand Therapy: PSMA and BeyondAndrei Gafita, Charles Marcus, Louise Kostos, et al.
Current Opinion in Supportive and Palliative Care|October 14, 2022
Systemic therapy in metastatic hormone-sensitive prostate cancerJodie McDonald, Jonathan O'Brien, Louise Kostos, et al.
Sarcoma|December 23, 2024
Oral Etoposide for Relapsed or Refractory Ewing Sarcoma in Adolescent and Adult PatientsLouise Kostos, Victoria Rayson, Jayesh Desai, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cancer Cell|November 4, 2022
KIT as a therapeutic target in neuroendocrine prostate cancerArun A Azad, Louise Kostos, Neeraj Agarwal
World Journal of Urology|August 27, 2022
Future directions in systemic treatment of metastatic hormone-sensitive prostate cancerKenneth Chen, Louise Kostos, Arun A Azad
Drugs|July 26, 2024
Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate CancerLouise Kostos, Ben Tran, Arun A Azad
Platelets|June 2, 2015
Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case reportLouise Kostos, Kate Burbury, Gaurav Srivastava, et al.
Seminars in Nuclear Medicine|June 19, 2024
Combination Strategies and Targeted Radionuclide TherapiesKerry Jewell, Louise Kostos, Brittany Emmerson, et al.
European Urology Focus|May 30, 2026
Radionuclide Combination Strategies in Prostate Cancer: Insights from the AlphaBet TrialLouise Kostos, James P Buteau, Arun A Azad, et al.
Therapeutic Advances in Medical Oncology|June 16, 2023
Determinants of outcome following PSMA-based radioligand therapy and mechanisms of resistance in patients with metastatic castration-resistant prostate cancerLouise Kostos, James P Buteau, Michael S Hofman, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 24, 2022
Predictors and Real-World Use of Prostate-Specific Radioligand Therapy: PSMA and BeyondAndrei Gafita, Charles Marcus, Louise Kostos, et al.
Current Opinion in Supportive and Palliative Care|October 14, 2022
Systemic therapy in metastatic hormone-sensitive prostate cancerJodie McDonald, Jonathan O'Brien, Louise Kostos, et al.
Sarcoma|December 23, 2024
Oral Etoposide for Relapsed or Refractory Ewing Sarcoma in Adolescent and Adult PatientsLouise Kostos, Victoria Rayson, Jayesh Desai, et al.
Pageof 3